Goodwin Names 35 New Partners

Global law firm Goodwin today announced that 35 lawyers have been elected to the firm’s partnership, effective immediately.

“Congratulations to our new class of partners who embody the essence of our firm,” said Anthony McCusker, Goodwin’s Chair. “Their leadership and unwavering commitment to our core values, clients and communities are integral to Goodwin’s continued success. We are pleased to welcome them to the firm’s partnership.”

Goodwin applauds:

	Folake Ayoola (Technology, Washington DC) advises public companies and their Board of Directors on securities regulation, capital market transactions, and corporate governance matters. She was formerly Senior Counsel in the Division of Corporation Finance at the SEC, where she reviewed transactions and disclosures under the Securities Act of 1933 and the Securities Exchange Act of 1934.
	Samuel Beavers (Life Sciences, Washington DC) specializing in complex transactions including mergers and acquisitions, venture capital financings, and joint ventures for companies at all stages of development. Sam also acts as outside general corporate counsel, providing guidance on commercial contracts and day-to-day corporate governance matters.
	Arman Carretta (Technology, Santa Monica) represents startups, growth companies, venture capitalists and growth investors. He regularly advises companies on company formation and structuring, general corporate counseling, corporate governance, capital raising and mergers and acquisitions. He also represents venture capital and private equity firms, as well as strategic acquirers in connection with their investments and mergers and acquisitions transactions.
	Alexandra Carter (Private Equity, London) advises private equity houses and other financial institutions on the formation of private equity, infrastructure and venture funds and co-investment vehicles. She also advises managers on a wide range of platform arrangements, including staff investment, carried interest and other incentivization schemes, team reorganizations and spin-outs.
	Brady P. P. Cummins (Complex Litigation & Dispute Resolution – Antitrust, Washington DC) advises clients on all aspects of antitrust issues related to mergers and acquisitions including US and international antitrust filing assessments, antitrust risk assessments, risk mitigation, antitrust-related agreement provisions, and FTC and DOJ investigations. He advocates on behalf of clients across a broad range of industries before the FTC, DOJ, and state enforcers during all aspects of merger investigations as well as conduct and cartel investigations.
	Lee Douthitt (Complex Litigation & Dispute Resolution – Employment, Boston) represents employers in a broad range of employment matters, including advising clients on compliance with laws affecting the workplace and providing employment-related corporate counseling on diverse types of mergers and acquisitions.
	Maria Dragun (Life Sciences, London) focuses on UK and cross-border transactions in the life sciences, healthcare and technology sectors, acting for companies as well as their investors. She has a broad corporate practice and advises on all stages of the corporate life cycle, including company formation, venture capital financings, mergers and acquisitions, reorganizations, and general life cycle matters.
	Joseph Flynn (Life Sciences, Boston) represents public and private companies at all stages of maturity as well as venture capital firms across the life sciences industry. He advises clients on a wide range of matters, including startup and formation, financings, mergers and acquisitions, transactional matters, and other complex transactions. He also counsels companies on ongoing corporate matters.
	Matthew Giannascoli (Private Equity, Washington DC) focuses primarily on mergers and acquisitions, venture capital and growth equity transactions, with an emphasis on representing private equity sponsors. He also represents private equity funds, venture capital funds and growth equity funds in minority investments, venture financings, and other capital-raising transactions.
	Jason Goldfarb (Technology, Boston) advises companies throughout their corporate lifecycle. He works with clients in a wide range of matters, including company formation, seed, venture capital and growth equity financings, mergers and acquisitions, public offerings, capital markets transactions and SEC compliance.
	Elena Hera (Real Estate Industry, New York) advises clients on a wide variety of ESG issues, including mandatory and voluntary reporting, regulatory compliance, ESG governance, development of ESG policies and procedures, anti-ESG considerations, fund formation and marketing, and ESG due diligence. She also serves as ongoing corporate and securities counsel for a diverse group of publicly traded companies, including real estate investment trusts. She regularly counsels clients on SEC and stock exchange compliance, and corporate governance matters, and has represented issuers and investment banks in connection with IPOs, registered equity and debt offerings, and ATM offerings.
	Heath R. Ingram (Life Sciences, New York) is an attorney for life sciences and healthcare companies, including biotechnology companies, pharmaceutical and medical device manufacturers, and digital health companies at all stages of development, as well as, venture capital and private equity firms focused on the healthcare industry. Heath focuses his practice on regulatory, corporate, investigations and enforcement actions.
	Mark Joseph (Private Equity, Los Angeles) focuses his practice on private equity transactions, including mergers and acquisitions, leveraged buyouts, and related matters.
	Natalia Kubik (Private Equity, New York) specializes in the formation, structuring, and ongoing operation of private investment funds across many asset classes. With expertise in private equity and venture capital, she offers strategic guidance to fund managers and investors throughout all stages of the fund lifecycle. Her practice also extends to secondary transactions.
	Tal Maman (Private Equity, New York) focuses on growth equity investments, venture capital financings and mergers and acquisitions transactions, as well as general corporate matters.
	Oana Millich (Private Equity, Luxembourg), has a core focus on the private equity sector, and experience across various other asset classes such as real estate, infrastructure and renewables funds, venture capital and secondaries, advising on a broad range of matters such as fund formation (including regulated and non-regulated funds), fundraising and carry and co-investment schemes. She also advises sponsors on investments and has extensive experience in corporate matters and funds financings.
	Folko Moroni (Private Equity, Munich) focuses his practice on leveraged acquisition finance and corporate finance. He represents banks, debt funds, financial sponsors, and corporate borrowers on diverse types of financings.
	Elizabeth Mulkey (Life Sciences, Washington DC) counsels pharmaceutical, biologic, medical device, digital health, and consumer product companies on FDA regulatory compliance issues, including advertising, promotion and labeling review, drug and device development issues, clinical trial conduct, interactions with FDA, internal corporate investigations, and responding to FDA inspection observations and enforcement actions. She also advises FDA-regulated entities in corporate transactions, offerings, and licensing matters.
	Annaka Nava (Intellectual Property Litigation, Washington DC) represents industry-leading companies in patent litigation matters in US district courts and the International Trade Commission (ITC) covering a variety of technology areas, including biotechnology, pharmaceuticals, medical devices, computer technology (hardware and software), telematics, semiconductor devices, and Wi-Fi location services.
	Jennifer Necas (Private Equity, New York) focuses primarily on the representation of borrowers and lenders in connection with debt financing transactions
	Trey O’Callaghan (Technology, Washington DC) focuses his practice on mergers and acquisitions and representing start-up and later-stage companies throughout their corporate life cycle. He also represents private equity funds, venture capital funds, and public companies in a variety of technology-driven industries.
	Manish Ranjan (Private Equity, Singapore) is a partner in Goodwin’s Private Investment Funds group.
	Ben Rosales (Technology, Silicon Valley) focuses on advising emerging growth companies at every stage of their corporate lifecycle, including pre-incorporation planning, general corporate representation and counseling, venture capital financings, and mergers and acquisitions. He also represents venture capital funds, growth equity funds and strategic investors in financing transactions from seed through growth stage.
	Jochen Schnepper (Real Estate Industry, Frankfurt) is a member of the Real Estate Finance & Restructurings practice, and its Financial industry group. He focuses his banking practice on real estate finance transactions, acting for a range of sponsor, borrower, and lender clients. He advises on senior and mezzanine structures, domestic and cross-border financings and has expertise in diverse types of financing products, including debt capital markets. Recently, Jochen Schnepper has dedicated a considerable part of his practice to financial restructurings, distressed debt investing, and other special situations.
	Dylan Schweers (Complex Litigation & Dispute Resolution – Commercial, Boston) focuses on private investment litigation, government and internal investigations, white collar criminal defense, regulatory enforcement proceedings, and corporate governance matters, with clients including companies, boards, and individuals in the healthcare, life sciences, technology, and financial industries.
	Devin Spencer (Private Equity, Santa Monica) advises private equity sponsors and their portfolio companies on a variety of domestic and cross-border transactions (including acquisitions, divestitures, leveraged buyouts and joint ventures), venture capital investors on domestic and international minority and growth equity investments, and each of the foregoing on general corporate and securities law matters.
	Ximeng (Sammy) Tang (Financial Services, New York) advises financial institutions, fintech companies and blockchain service providers on complex, multi-jurisdictional banking laws and financial services regulations. She counsels clients in structuring and papering lending, payments and digital asset products and programs, including drafting and negotiating bank partnership agreements, preparing consumer-facing disclosures and terms, and evaluating state and federal level regulatory risks.
	Kathleen Treaster (Intellectual Property Litigation, Boston) focuses her practice on patent litigation, with an emphasis on biotechnology and pharmaceuticals.
	Emily Unger (Complex Litigation & Dispute Resolution – Commercial Litigation, Boston) focuses her practice on a broad range of internal and government investigations and complex business disputes and litigation, representing private investment sponsor clients in a variety of post-closing matters, including matters arising out of escrow and indemnification disputes, restrictive covenant violations, and breaches of contract. She also represents public and private life sciences and technology companies and their boards, officers, and directors through criminal and civil government investigations, internal corporate investigations, whistleblower issues, and litigation arising out of these matters.
	Lauren Visek (Technology, Washington DC) counsels public companies and their Board of Directors on securities regulation, capital market transactions, and corporate governance matters.
	Justin Ward (Complex Litigation & Dispute Resolution – Securities, Boston) focuses on securities class actions, SEC investigations, mergers and acquisitions litigation, and corporate governance matters, in particular for life sciences and technologies companies. Justin also regularly represents private equity firms and their portfolio companies in post-closing, corporate governance, indemnification, and contract disputes.
	Rebecca Wardle (Complex Litigation & Dispute Resolution – Commercial Litigation, London) represents clients in contentious matters and investigations across multiple industries, including private equity, funds, technology and life sciences, and financial services. Rebecca has particular expertise in shareholder disputes.
	Simone Waterbury (Complex Litigation & Dispute Resolution – Antitrust, Boston) focuses her practice on advising domestic and multinational businesses and private equity firms on their obligations under the Hart-Scott-Rodino Antitrust Improvements Act and foreign merger control and direct investment regimes, assessing reportability and transaction-related antitrust risk for a wide variety of complex transactions and cross border deals involving mergers, license agreements, investment funds, and financing transactions.
	Amarilice Young (Life Sciences, Boston) works with life sciences companies throughout the corporate lifecycle – from startup and commercial-stage to maturity – as well as investors, banks, and others in the life sciences ecosystem.
	Toby Young (Real Estate Industry, London) advises UK and overseas sponsors, private equity firms, asset managers and financial institutions and other debt/equity providers on all aspects of real estate finance. He has substantial experience acting for real estate sponsors on borrower mandates and as lender counsel for the deployment of real estate focused debt funds.